These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 993324)

  • 1. Effects of growth hormone in osteoporosis.
    Aloia JF; Zanzi I; Ellis K; Jowsey J; Roginsky M; Wallach S; Cohn SH
    J Clin Endocrinol Metab; 1976 Nov; 43(5):992-9. PubMed ID: 993324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
    Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for osteoporosis.
    Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
    Metabolism; 1977 Jul; 26(7):787-92. PubMed ID: 559229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.
    Johansson AG; Lindh E; Blum WF; Kollerup G; Sørensen OH; Ljunghall S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):44-8. PubMed ID: 8550792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
    Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone.
    Hock JM; Fonseca J
    Endocrinology; 1990 Oct; 127(4):1804-10. PubMed ID: 2401235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New drugs with positive effects on bones].
    Zofková I; Kanceva RL
    Cas Lek Cesk; 1997 Jul; 136(15):459-63. PubMed ID: 9340191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On an attempt to treat primary and secondary osteoporosis with human growth hormone.
    Kruse HP; Kuhlencordt F
    Horm Metab Res; 1975 Nov; 7(6):488-91. PubMed ID: 1213656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone.
    Giustina A; Bussi AR; Jacobello C; Wehrenberg WB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):122-9. PubMed ID: 7829600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
    Plotkin H; Gundberg C; Mitnick M; Stewart AF
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium supplementation increases bone mass in GH-deficient prepubertal children during GH replacement.
    Zamboni G; Antoniazzi F; Lauriola S; Bertoldo F; Tatò L
    Horm Res; 2006; 65(5):223-30. PubMed ID: 16569932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.
    Riggs BL; Jowsey J; Goldsmith RS; Kelly PJ; Hoffman DL; Arnaud CD
    J Clin Invest; 1972 Jul; 51(7):1659-63. PubMed ID: 4338118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial.
    Landin-Wilhelmsen K; Nilsson A; Bosaeus I; Bengtsson BA
    J Bone Miner Res; 2003 Mar; 18(3):393-405. PubMed ID: 12619921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.